Amgen Czech Republic made a net profit of CZK CZK 35.8 mil under revenues of CZK 604 mil in 2015, down 11.4% and -5.06%, respectively, when compared to the last year.
This translates into a net margin of 5.93%. Historically, the firm’s net margin reached an all time high of 11.3% in 2008 and an all time low of 4.61% in 2005. The average net margin in the last five years amounted to 7.24%.
On the operating level, EBITDA margin reached 7.34% and EBIT amounted to 7.66% of sales in 2015.
As far as Amgen Czech Republic's peers are concerned, Roche Czech Republic posted net and EBITDA margin of 0.936% and 3.84%, respectively in 2015 and Bayer Czech Republic generated margins of 2.89% and 3.93%.